Literature DB >> 23912648

Serum analysis of coagulation factors in IPF and NSIP.

E Bargagli1, C Madioni, N Bianchi, R M Refini, R Cappelli, P Rottoli.   

Abstract

Recent literature and our previous proteomic findings prompted us to study the coagulation system in idiopathic pulmonary fibrosis (IPF), the pathogenesis of which remains unclear. The aim of this study was to compare coagulation factors in idiopathic pulmonary fibrosis and idiopathic nonspecific interstitial pneumonia (NSIP) patients and healthy controls. Thirty-three IPF patients (23 acute exacerbation and 10 stable IPF patients), 7 NSIP patients, and 44 controls were enrolled. Concentrations of D-dimer, homocysteine, functional protein C, protein C antigen, free and total protein S antigen and activity, fibrinogen and factor VIIIc were analyzed in serum of patients and controls. The lupus anticoagulant (LAC) test was also performed. Factor VIIIc levels were significantly higher in acute exacerbation IPF patients than controls (p = 0.0001) and in stable IPF patients than controls (p = 0.002). Factor VIIIc levels were higher and PT levels were lower in acute exacerbation IPF patients who died after exacerbation than in patients who survived (p = 0.04 and p = 0.003, respectively). D-dimer, fibrinogen, and homocysteine levels were also significantly higher in IPF patients than controls (p < 0.01). Protein C activity was increased in acute exacerbation IPF patients than controls (p = 0.005). The LAC test was positive in seven IPF patients and negative in controls. Procoagulant status was demonstrated in IPF patients (mainly in acute exacerbation/IPF) than controls and NSIP patients, probably due to endothelial activation and microvascular injury. These preliminary results are of interest because of their potential implications in the pathogenesis and treatment of this disease.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 23912648     DOI: 10.1007/s10753-013-9706-z

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  28 in total

1.  Idiopathic pulmonary fibrosis related to endothelial injury and antiendothelial cell antibodies.

Authors:  Cynthia M Magro; W James Waldman; Deborah A Knight; James N Allen; Tibor Nadasdy; Gwyn E Frambach; Patrick Ross; Clay B Marsh
Journal:  Hum Immunol       Date:  2006-04-05       Impact factor: 2.850

Review 2.  [Management of acute exacerbations of pulmonary fibrosis].

Authors:  J-M Naccache; H Mal
Journal:  Rev Mal Respir       Date:  2011-03-22       Impact factor: 0.622

3.  Protein S in cancer patients with non-metastatic solid tumours.

Authors:  S Battistelli; A Vittoria; R Cappelli; M Stefanoni; F Roviello
Journal:  Eur J Surg Oncol       Date:  2005-09       Impact factor: 4.424

4.  Antiinflammatory and antifibrotic effects of the oral direct thrombin inhibitor dabigatran etexilate in a murine model of interstitial lung disease.

Authors:  Galina S Bogatkevich; Anna Ludwicka-Bradley; Paul J Nietert; Tanjina Akter; Joanne van Ryn; Richard M Silver
Journal:  Arthritis Rheum       Date:  2011-05

Review 5.  [Acute exacerbation of idiopathic pulmonary fibrosis].

Authors:  José Manuel Valle Vázquez; José Manuel Alvarez Dobaño; Francisco Javier González Barcala; Luis Valdés Cuadrado
Journal:  Med Clin (Barc)       Date:  2010-03-15       Impact factor: 1.725

6.  Anticoagulant therapy for idiopathic pulmonary fibrosis.

Authors:  Hiroshi Kubo; Katsutoshi Nakayama; Masaru Yanai; Tomoko Suzuki; Mutsuo Yamaya; Mika Watanabe; Hidetada Sasaki
Journal:  Chest       Date:  2005-09       Impact factor: 9.410

Review 7.  Proteome analysis of bronchoalveolar lavage in lung diseases.

Authors:  Barbara Magi; Elena Bargagli; Luca Bini; Paola Rottoli
Journal:  Proteomics       Date:  2006-12       Impact factor: 3.984

8.  The role of microvascular injury in the evolution of idiopathic pulmonary fibrosis.

Authors:  Cynthia M Magro; James Allen; Amy Pope-Harman; W James Waldman; Patrick Moh; Susan Rothrauff; Patrick Ross
Journal:  Am J Clin Pathol       Date:  2003-04       Impact factor: 2.493

9.  Decreased protein C activation is associated with abnormal collagen turnover in the intraalveolar space of patients with interstitial lung disease.

Authors:  H Yasui; E C Gabazza; O Taguchi; J Risteli; L Risteli; H Wada; H Yuda; T Kobayashi; H Kobayashi; K Suzuki; Y Adachi
Journal:  Clin Appl Thromb Hemost       Date:  2000-10       Impact factor: 2.389

Review 10.  Current view on alveolar coagulation and fibrinolysis in acute inflammatory and chronic interstitial lung diseases.

Authors:  Malgorzata Wygrecka; Ewa Jablonska; Andreas Guenther; Klaus T Preissner; Philipp Markart
Journal:  Thromb Haemost       Date:  2008-03       Impact factor: 5.249

View more
  16 in total

1.  Reply to D'Alessandro-Gabazza et al.: Risks of Treating Idiopathic Pulmonary Fibrosis with a TAM Receptor Kinase Inhibitor.

Authors:  Milena S Espindola; David M Habiel; Cory M Hogaboam
Journal:  Am J Respir Crit Care Med       Date:  2018-10-01       Impact factor: 21.405

2.  Increased platelet binding to circulating monocytes in idiopathic pulmonary fibrosis.

Authors:  Ahmed Fahim; Michael G Crooks; Alyn H Morice; Simon P Hart
Journal:  Lung       Date:  2014-01-07       Impact factor: 2.584

3.  Mortality on the Waiting List for Lung Transplantation in Patients with Idiopathic Pulmonary Fibrosis: A Single-Centre Experience.

Authors:  David Bennett; Antonella Fossi; Elena Bargagli; Rosa Metella Refini; Maria Pieroni; Luca Luzzi; Claudia Ghiribelli; Piero Paladini; Luca Voltolini; Paola Rottoli
Journal:  Lung       Date:  2015-07-28       Impact factor: 2.584

4.  Extracellular Vesicle Surface Signatures in IPF Patients: A Multiplex Bead-Based Flow Cytometry Approach.

Authors:  Miriana d'Alessandro; Piera Soccio; Laura Bergantini; Paolo Cameli; Giulia Scioscia; Maria Pia Foschino Barbaro; Donato Lacedonia; Elena Bargagli
Journal:  Cells       Date:  2021-04-28       Impact factor: 6.600

5.  Evaluation of the relationship between laboratory parameters and pulmonary function tests in COVID-19 patients.

Authors:  Buğra Kerget; Alperen Aksakal; Ferhan Kerget
Journal:  Int J Clin Pract       Date:  2021-04-27       Impact factor: 3.149

6.  The utility of the Japanese Association for Acute Medicine DIC scoring system for predicting survival in acute exacerbation of fibrosing idiopathic interstitial pneumonia.

Authors:  Ryo Yamazaki; Osamu Nishiyama; Sho Saeki; Hiroyuki Sano; Takashi Iwanaga; Yuji Tohda
Journal:  PLoS One       Date:  2019-08-19       Impact factor: 3.240

7.  Biomarker profiles of coagulopathy and alveolar epithelial injury in acute respiratory distress syndrome with idiopathic/immune-related disease or common direct risk factors.

Authors:  Kansuke Koyama; Shinshu Katayama; Ken Tonai; Jun Shima; Toshitaka Koinuma; Shin Nunomiya
Journal:  Crit Care       Date:  2019-08-19       Impact factor: 9.097

8.  Efficacy of thrombomodulin for acute exacerbation of idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia: a nonrandomized prospective study.

Authors:  Mitsuhiro Abe; Kenji Tsushima; Takuma Matsumura; Tsukasa Ishiwata; Yasunori Ichimura; Jun Ikari; Jiro Terada; Yuji Tada; Seiichirou Sakao; Nobuhiro Tanabe; Koichiro Tatsumi
Journal:  Drug Des Devel Ther       Date:  2015-10-23       Impact factor: 4.162

Review 9.  Patients with Interstitial Lung Disease Secondary to Autoimmune Diseases: How to Recognize Them?

Authors:  Domenico Sambataro; Gianluca Sambataro; Francesca Pignataro; Giovanni Zanframundo; Veronica Codullo; Evelina Fagone; Emanuele Martorana; Francesco Ferro; Martina Orlandi; Nicoletta Del Papa; Lorenzo Cavagna; Lorenzo Malatino; Michele Colaci; Carlo Vancheri
Journal:  Diagnostics (Basel)       Date:  2020-04-09

10.  Haemostatic, fibrinolytic and inflammatory profiles in West Highland white terriers with canine idiopathic pulmonary fibrosis and controls.

Authors:  Elodie Roels; Natali Bauer; Christelle Lecut; Andreas Moritz; André Gothot; Cécile Clercx
Journal:  BMC Vet Res       Date:  2019-10-29       Impact factor: 2.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.